136 related articles for article (PubMed ID: 7857338)
1. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
[TBL] [Abstract][Full Text] [Related]
2. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
Annoni G; Arosio B; Santambrogio D; Cullurà D; Gagliano N; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
[TBL] [Abstract][Full Text] [Related]
3. Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.
Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Bernardini R
Pharmacol Toxicol; 1994; 74(4-5):262-6. PubMed ID: 8090697
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating activity of pidotimod.
Migliorati G; Nicoletti I; Riccardi C
Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
[TBL] [Abstract][Full Text] [Related]
5. Experimental immunological screening tests on pidotimod.
Coppi G; Manzardo S
Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
[TBL] [Abstract][Full Text] [Related]
6. [Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study].
Borghi MO; Minonzio F; Fain C; Carbonelli V; Barcellini W; Del Papa N; La Rosa L; Piona A; Gambini D; Meroni PL
Drugs Exp Clin Res; 1993; 19 Suppl():37-43. PubMed ID: 8625781
[No Abstract] [Full Text] [Related]
7. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
Taramelli D; Malabarba MG; Basilico N; Sala G; Mattina R; Cocuzza C
Arzneimittelforschung; 1994 Dec; 44(12A):1425-30. PubMed ID: 7857336
[TBL] [Abstract][Full Text] [Related]
8. The in vitro effect of Pidotimod on some immune functions in cancer patients.
Di Renzo M; Pasqui AL; Bruni F; Saletti M; Bova G; Chiarion C; Girardello R; Ferrì P; Auteri A
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):37-51. PubMed ID: 9049658
[TBL] [Abstract][Full Text] [Related]
9. [Levels of interleukin-2 )IL-2 and tumor necrosis factor alpha (TNF-alpha) mRNA in aged rat spleen under physiological conditions and in septic shock: possible role of pidotimod in gene expression modulation].
Arosio B; Santambrogio D; Gagliano N; Annoni G
Drugs Exp Clin Res; 1993; 19 Suppl():9-14. PubMed ID: 8625783
[No Abstract] [Full Text] [Related]
10. In vivo antiviral effects of pidotimod.
Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
[TBL] [Abstract][Full Text] [Related]
11. General pharmacology of pidotimod and testing for drug interactions.
Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
[TBL] [Abstract][Full Text] [Related]
13. Toxicological evaluation of pidotimod.
Coppi G; Amico-Roxas M; Bertè F; Bussi R; Gnemi P; Harling RJ; Mailland F; Manzardo S; Massey JE; Spencer-Briggs DJ
Arzneimittelforschung; 1994 Dec; 44(12A):1448-53. PubMed ID: 7857340
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of pidotimod in rats and dogs.
Coppi G; Silingardi S
Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
[TBL] [Abstract][Full Text] [Related]
15. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
16. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Migliorati G; D'Adamio L; Coppi G; Nicoletti I; Riccardi C
Immunopharmacol Immunotoxicol; 1992; 14(4):737-48. PubMed ID: 1294620
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
Bisetti A; Ciappi G; Bariffi F; Catena E; Rocco V; Vaccaro L; Grassi V; Scarpazza G; Bertoli L; Cardani A
Arzneimittelforschung; 1994 Dec; 44(12A):1499-502. PubMed ID: 7857351
[TBL] [Abstract][Full Text] [Related]
19. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
Passali D; Calearo C; Conticello S
Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
[TBL] [Abstract][Full Text] [Related]
20. Immunoactivation by pidotimod in children with recurrent respiratory infections.
Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
